# US 2025/0154138 A1 · Small Molecule IL-17A Modulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154138 A1
- Document ID: US20250154138A1
- Status: Published application
- Kind: A1
- Application number: 18/918,712
- Filed: 2024-10-17
- Published: 2025-05-15
- Earliest claimed: 2022-04-21
- Assignees: BeiGene, Ltd.
- Applicants: BeiGene, Ltd.
- Inventors: Hai Xue; Yunhang Guo; Si Chen; Zhiwei Wang
- Web page: https://patentgrep.com/patent/US20250154138A1

## CPC

- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D 409/14: containing three or more hetero rings
- A61K 31/4178: not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A61K 31/4245: Oxadiazoles
- A61K 31/527: spiro-condensed
- C07D 231/14: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 239/70: condensed with carbocyclic rings or ring systems
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 403/14: containing three or more hetero rings
- C07D 405/14: containing three or more hetero rings
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 417/14: containing three or more hetero rings
- C07D 487/04: Ortho-condensed systems
- C07D 498/04: Ortho-condensed systems
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed herein are fused bi-cyclic compounds used as Small Molecule IL-17A Modulators. Disclosed herein is the use of these Small Molecule IL-17A Modulators for the use of decreasing IL-17 activity by inhibition, and the use of such compounds for the use in the treatment of autoimmune diseases or inflammatory diseases.

## Claims

### Claim 1

A compound of Formula (I):
or a N-oxide thereof, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a deuterated analog thereof, wherein:
Cy1 is a 5-6 membered aromatic ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R3;
n3 is independently 0, 1, 2 or 3;
Cy2 is a 4-8 membered saturated or partially or completely unsaturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur; said ring is substituted with at least one substituent R1 and/or R2;
n1 is 0 or 1;
n2 is 0, 1 or 2;
n1 and n2 are not 0 at the same time;
Cy1 and Cy2 are fused with each other;
Cy3 is a 3-12 membered saturated or partially or completely unsaturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur; said ring is optionally substituted with at least one substituent R6;
n6 is independently 0, 1, 2, 3, 4 or 5, provided that the valency theory is met;
X1 is a single bond or —CR9R10—;
R1 is independently selected from H or
wherein X2 is N or C(R15);
X3 is —C(O)—, —S(O)— or —S(O)2—;
n11 and n12 are each independently 1, 2 or 3;
n14 is 0 or 1;
R15 is selected from hydrogen, halogen, —C1-8alkyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —CN, —OR15a, —NR15aR15b, or —NR15aCOR15b; each of —C1-8alkyl, C3-C8cycloalkyl and 3- to 8-membered heterocyclyl is optionally substituted with at least one substituent R15c,
R15a and R15b are each independently selected from hydrogen, —C1-8alkyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl, each of —C1-8alkyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8 alkyl-, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R15d;
R15c and R15d, at each occurrence, are each independently halogen, —OH, —CN, oxo, —C1-8alkyl, —C1-8 haloalkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R11a, R11b, R12a and R12b are each independently selected from hydrogen, halogen, —C1-8alkyl, —C2-8alkenyl, —C2-8-alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, —CN, —OR11c, —COR11c, —CO2R11c, —CONR11cR11d, —NR11cR11d or —NR11cCOR11d; each of —C1-8alkyl, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R11°, or
(R11a and R11b), (R12a and R12b), (R11a and R12a), (R11a and R12b), (R11b and R12a) or (R11b and R12b) together with the atom(s) to which they are attached, form a 3- to 8-membered unsaturated or saturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R11f;
R11e, and R11f, at each occurrence, are each independently hydrogen, halogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, oxo (═O), —OR11g, thioxo (═S), —SR11g, —CN, —SO2R11g, —SO2NR11gR11h, —COR11g, —CO2R11h, —CONR11gR11h, —NR11gR11h, —NR11gCOR11h, —NR11gCO2R11h or —NR11gSO2R11h; each of —C1-8alkyl, —C1-8alkoxy, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R11i;
R11c, R11d, R11g and R11h are each independently selected from hydrogen, —C1-8alkyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8 alkoxy-C1-8alkyl-, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R11j;
at each occurrence, R11i and R11j are each independently halogen, —OH, —CN, oxo, —C1-8alkyl, —C1-8haloalkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent halogen, —OH, —CN, oxo, —C1-8alkyl, —C1-8haloalkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R13, R14a and R14b are each independently selected from hydrogen, —C1-8alkyl, —C3-C8cycloalkyl or 3- to 8-membered heterocyclyl; each of —C1-8alkyl, —C3-C8cycloalkyl and 3- to 8-membered heterocyclyl is optionally substituted with at least one substituent R13a;
R13a, at each occurrence, is independently halogen, —OH, —CN, oxo, —C1-8alkyl, —C1-8haloalkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R2 is independently selected from H, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl, 5- to 12-membered heteroaryl, —CN, —COR2a, —CO2R2a, —CONR2aR2b, —NR2aR2b, or —NR2aCOR2b, each of —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R2c; or
when geminal or adjacent, two R2 together with the carbon atom(s) to which they are attached, form a 3- to 8-membered unsaturated or saturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R2c;
R2a and R2b are each independently selected from hydrogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R2d; or
R2a and R2b together with the nitrogen atom to which they are attached, form a 3- to 8-membered unsaturated or saturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R2d;
R2c and R2d, at each occurrence, are each independently hydrogen, halogen, —C1-8alkyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, oxo (═O), —OR2, —SR2e, —CN, —COR2e, —CO2R2e, —CONR2eR2, —NR2eR2, —NR2eCOR2f or —NR2eCO2R2f; each of —C1-8alkyl, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R2g;
R2e and R2f are each independently selected from hydrogen, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8 alkyl-, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R2h;
R2g and R2h, at each occurrence, are each independently halogen, —OH, —C1-8alkyl, —C1-8haloalkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
when n1 and n2 are both 1, R1 and R2 are geminal or adjacent;
R3 is independently selected from hydrogen, halogen, —C1-8alkyl, —C1-8alkoxy, —C3-C8cycloalkyl, or —CN, wherein each of —C1-8alkyl, —C1-8alkoxy and —C3-C8cycloalkyl is optionally substituted with at least one substituent selected from halogen, —OH, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R4 is oxo (═O) or thioxo (═S); or
R3 and R4 together with the atoms to which they are attached, form a 5- to 6-membered aromatic ring, said ring comprising 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R3a;
R3a is independently selected from hydrogen, halogen, —C1-8alkyl, —C1-8alkoxy, —C3-C8cycloalkyl, or —CN, wherein each of —C1-8alkyl, —C1-8alkoxy and —C3-C8cycloalkyl is optionally substituted with at least one substituent selected from halogen, —OH, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R5 is C6-C12aryl, 5- to 12-membered heteroaryl, —COR5a, —CO2R5a, —CONR5aR5b, wherein each of C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R5c;
R5a and R5b are each independently selected from —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C2-8-alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R5d; or
R5a and R5b together with the atom to which they are attached, form a 3- to 8-membered unsaturated or saturated ring, said ring comprising 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R5d;
R5c and R5d, at each occurrence, are each independently selected from hydrogen, halogen, —C1-8alkyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, oxo (═O), —OR5e, —SR5e, —CN, —COR5e, —CO2R5e, —CONR5eR5d, —NR5eR5f, —NR5eCOR5f or —NR5eCO2R5f; each of —C1-8alkyl, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R5g;
R5e and R5fare each independently selected from hydrogen, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8 alkyl-, —C2-8alkenyl, —C2-8alkynyl, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R5h;
R5g and R5h are each independently selected from halogen, —OH, —CN, —C1-8alkyl, —C1-8alkoxy, C1-8 alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R6 is H, halogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl, 5- to 12-membered heteroaryl, —CN, —OR6a, —NR6aR6b, —COR6a, —CO2R6a, —CONR6aR6b, —COR6a or —NR6aCOR6beach of —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R6e;
R6a and R6b are each independently selected from hydrogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl; each of —C1-8alkyl, —C2-8-alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent Rd;
R6c, at each occurrence, is independently hydrogen, halogen, —C1-8alkyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, oxo (═O), —OR6e, —SR6e, —CN, —COR6e, —CO2R6e, —CONR6eR6f, —NR6eR6f—NR6eCOR6f or —NR5eCO2R6f; each of —C1-8alkyl, C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R6g;
R6e and R6f are each independently selected from hydrogen, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8 alkyl-, —C2-8alkenyl, —C2-8alkynyl, C3-C12cycloalkyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl;
R6d and R6g are each independently selected from halogen, —OH, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
R7 and R8 are each independently hydrogen;
R9 and R10 are each independently selected from H, halogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl or 5- to 12-membered heteroaryl, each of —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R9a; and
R9a, at each occurrence, is independently halogen, —OH, —C1-8alkyl, —C1-8alkoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, —C3-C8cycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound is selected from Formula (IIa)-(IIp):
wherein, R1, R2, R3, R4, R5, R6, R7, R8, Cy3, n1, n2, n3, n6 and X1 are defined as in claim 1.

### Claim 3 (depends on 1)

The compound of claim 1, wherein the compound is selected from Formula (IIf1)-(IIf2):
wherein, R1, R2, R3, R4, R5, R6, R7, R8, Cy3, n1, n2, n3, n6 and X1 are defined as in claim 1.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the compound is selected from Formula (IIIa)-(IIIb):
wherein, R1, R2, R3, R4, R5, R6, R7, R8, Cy1, Cy2, Cy3, n1, n2, n3, n6, R9 and R10 are defined as in claim 1.

### Claim 5 (depends on 1)

The compound of claim 1, wherein the compound is selected from Formula (IVa)-(IVb):
wherein, X1, R1, R2, R3, R5, R6, R7, R8, Cy1, Cy2, Cy3, n1, n2, n3, n6, R9 and R10 are defined as in claim 1.

### Claim 6 (depends on 1)

The compound of claim 1, wherein the compound is selected from Formula (Va)-(Vc):
wherein, X1, R1, R2, R3, R4, R5, R6, R7, R8, Cy1, Cy2, Cy3, n3, n6, R9 and R10 are defined as in claim 1.

### Claim 7 (depends on 1)

The compound claim 1, wherein the compound is VIa,
preferably, the compound is selected from VIb and VIc
wherein, X1, X2, X3, R2, R3, R4, R5, R6, R7, R8, Cy1, Cy2, Cy3, n2, n3, n6, R11a, R11b, R12a, R12b, R13, R14a, R14b, n11, n12 and n14 are defined as in claim 1.

### Claim 8 (depends on 1)

The compound claim 1, wherein the compound is VIIa or VIIb,
preferably, the compound is selected from VIIc, VIId, VIIe, VIIf, VIIg or VIIh,
wherein, X2, R2a, R3, R5, R6, R9, R10, Cy1, Cy2, Cy3, n2, n3, n6, R11a, R11 b, R12a, R12b, R13, R14a, R14b, n11, n12 and n14 are defined as in claim 1.

### Claim 9

The compound of any one of the preceding claims, wherein Cy1 is a 5- or 6-membered aromatic ring, said ring comprising 0, 1 or 2 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with 0, 1, 2 or 3 substituents R3;
preferably, Cy1 is phenyl, pyridyl, thiophenyl, imidazolyl, furanyl or pyrazolyl; each of phenyl, pyridyl, thiophenyl, imidazolyl, furanyl or pyrazolyl is optionally substituted with 0, 1 or 2 substituents R3.

### Claim 10

The compound of any one of the preceding claims, wherein Cy2 a 4-, 5-, 6-, 7- or 8-membered saturated or partially or completely unsaturated ring, said ring comprising 0, 1, 2 or 3 heteroatoms independently selected from nitrogen or oxygen; said ring is substituted with at least one substituent R1 and/or R2;
preferably, Cy2 a 5-, 6- or 7-membered saturated or partially or completely unsaturated ring, said ring comprising 0, 1 or 2 heteroatoms independently selected from nitrogen or oxygen; said ring is substituted with at least one substituent R1 and/or R2.

### Claim 11

The compound of any one of the preceding claims, wherein
moiety is selected from:

### Claim 12

The compound of any one of the preceding claims, wherein Cy3 is a 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-membered saturated or partially or completely unsaturated ring, said ring comprising 0, 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur; said ring is optionally substituted with 0, 1, 2, 3, 4 or 5 substituent R6;
preferably, Cy3 is a 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-membered saturated or partially or completely unsaturated ring, said ring is mono-cycle, bi-cycle or tri-cycle comprising 0, 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur; said ring is optionally substituted with 0, 1, 2, 3, 4 or 5 substituent R6;
more preferably,
moiety is
even more preferably,
moiety is

### Claim 13 (depends on 1)

The compound of any one of the preceding claims, wherein R1 is independently selected from
wherein R11a, R11b, R12a, R12b, R13, n11 and n12 are defined as in claim 1.

### Claim 14

The compound of any one of the preceding claims, wherein R15 is selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, —CN, —OR15a, —NR15aR15b, or —NR15aCOR15b; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and 3- to 8-membered heterocyclyl is optionally substituted with at least one substituent R15e;
R15a and R15b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl, each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, —C2-8alkenyl, —C2-8alkynyl, C1-8 alkoxy-C1-8alkyl-, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, C6-C12aryl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R15d;
R15c and R15d, at each occurrence, are each independently —F, —Cl, —Br, —I, —OH, —CN, oxo, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl.

### Claim 15

The compound of any one of the preceding claims, wherein R15 is selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, —CN, —OH, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy;
preferably, R15 is selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl;
more preferably, R15 is selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl;
even more preferably, R15 is selected from hydrogen.

### Claim 16

The compound of any one of the preceding claims, wherein R11a, R11b, R12a and R12b are each independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, —CN; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl is optionally substituted with at least one substituent R11e;
R11e at each occurrence, is independently hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, oxo (═O), —OR11g, thioxo (═S), —SR11g, —CN, —SO2R11g, —SO2NR11gR11h, —COR11g, —CO2R11h, —CONR11gR11h, —NR11gR11h, —NR11gCOR11h, —NR11gCOR2R11h or —NR11gSOR2R11h; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl is optionally substituted with at least one substituent R11i;
R11c, R11d, R11g and R11h are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8 haloalkyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl and 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R11j;
at each occurrence, R11i and R11j are each independently —F, —Cl, —Br, —I, —OH, —CN, oxo, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl is optionally substituted with at least one substituent —F, —Cl, —Br, —I, —OH, —CN, oxo, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl.

### Claim 17

The compound of any one of the preceding claims, wherein R11a, R11b, R12a and R12b are each independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, —CN; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl is optionally substituted with at least one substituent R11e;
R11e at each occurrence, is independently hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, vinyl, propenyl, allyl, but-3-en-1-yl, but-2-en-1-yl, but-1-en-1-yl, pent-4-en-1-yl, pent-3-en-1-yl, pent-2-en-1-yl, pent-1-en-1-yl, hex-5-en-1-yl, hex-4-en-1-yl, hex-3-en-1-yl, hex-2-en-1-yl, hex-1-en-1-yl, hept-6-en-yl, hept-5-en-yl, hept-4-en-yl, hept-3-en-yl, hept-2-en-yl, hept-1-en-yl, oct-7-en-yl, oct-6-en-yl, oct-5-en-yl, oct-4-en-yl, oct-3-en-yl, oct-2-en-yl, oct-1-en-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl, pent-4-yn-1-yl, pent-3-yn-1-yl, pent-2-yn-1-yl, pent-1-yn-1-yl, hex-5-yn-1-yl, hex-4-yn-1-yl, hex-3-yn-1-yl, hex-2-yn-1-yl, hex-1-yn-1-yl, hept-6-yn-yl, hept-5-yn-yl, hept-4-yn-yl, hept-3-yn-yl, hept-2-yn-yl, hept-1-yn-yl, oct-7-yn-yl, oct-6-yn-yl, oct-5-yn-yl, oct-4-yn-yl, oct-3-yn-yl, oct-2-yn-yl, oct-1-yn-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, —OR11g or —CN;
R11g is independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl;
preferably, R11a, R11b, R12a and R12b are each independently selected from H, —CH3, —CF3, —CH2CH3, —CH2CF3, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, pentyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, pyrrolidinyl, tetrahydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, benzyl, vinyl, propenyl, allyl, but-3-en-1-yl, ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, but-3-yn-1-yl, but-2-yn-1-yl, but-1-yn-1-yl,

### Claim 18

The compound of any one of the preceding claims, wherein (R11a and R11b), (R12a and R12b), (R11aand R12a), (R11a and R12b), (R11b and R12a) or (R11b and R12b) together with the carbon atoms to which they are attached, form a 3-, 4-, 5-, 6- or 8-membered unsaturated or saturated ring, said ring comprising 0, 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R11f;
R11f, at each occurrence, is independently hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, C6-C12aryl, 5- to 12-membered heteroaryl, oxo (═O), —OR11g, thioxo (═S), —SR11g, —CN, —SO2R11g, —SO2NR11gR11h, —COR11g, —CO2R11h, CONR11gR11h, —NR11gR11h, —NR11gCOR11h, —NR11gCO2R11h or —NR11gSO2R11h;
R11g and R11h are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, C1-8alkoxy-C1-8alkyl-, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, C6-C12aryl or 5- to 12-membered heteroaryl;
at each occurrence, R11i is independently —F, —Cl, —Br, —I, —OH, —CN, oxo, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
preferably, (R11a and R11b), (R12a and R12b), (R11a and R12a), (R11a and R12b), (R11b and R12a) or (R11b and R12b) together with the carbon atoms to which they are attached, form a 3-, 4-, 5-, 6- or 8-membered unsaturated or saturated ring;
more preferably, (R11a and R11b), (R12a and R12b), (R11a and R12a), (R11a and R12b), (R11b and R12a) or (R11b and R12b) together with the carbon atoms to which they are attached, form a 3-, 4-, 5-, 6- or 8-membered saturated ring;

### Claim 19

The compound of any one of the preceding claims, wherein R13, R14a and R14b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or 3- to 8-membered heterocyclyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or 3- to 8-membered heterocyclyl is optionally substituted with at least one substituent R13a;
R13a, at each occurrence, is independently halogen, —OH, —CN, oxo, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C1-8haloalkyl, —C1-8alkoxy, —C2-8alkenyl, —C2-8alkynyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl;
preferably, R13, R14a and R14b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or 3- to 8-membered heterocyclyl;
more preferably, R13 is hydrogen, methyl, ethyl, propyl or butyl; R14a and R14b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or 3- to 8-membered heterocyclyl;
even more preferably, R13 is hydrogen; R14a and R14b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, cyclopropyl, cyclobutyl, cyclopentyl.

### Claim 20

The compound of any one of the preceding claims, wherein R1 is selected from

### Claim 21

The compound of any one of the preceding claims, wherein R2 is independently selected from H, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, —CN, —COR2a, —CO2R2a, —CONR2aR2b, —NR2aR2b, —NR2aCOR2b, each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl and imidazopyridinyl is optionally substituted with at least one substituent R2c;
R2a and R2b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl is optionally substituted with at least one substituent R2d; or
R2a and R2b together with the carbon atoms to which they are attached, form a 3-, 4-, 5-, 6-, 7- or 8-membered unsaturated or saturated ring, said ring comprising 0, 1, 2, 3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R2d;
R2c and R2d, at each occurrence, are each independently hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, oxo (═O), —OR2e, —SR2e, —CN, —COR2e, —CO2R2e, —CONR2eR2f, —NR2eR2f, —NR2eCOR2f or —NR2eCO2R2f; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl is optionally substituted with at least one substituent R2g;
R2e and R2fare each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8 alkyl-, —C1-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R2h
R2g and R2h, at each occurrence, are each independently —F, —Cl, —Br, —I, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C1-8haloalkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C3-C8halocycloalkyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl.

### Claim 22

The compound of any one of the preceding claims, wherein R2 is independently selected from H, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, —CN, —COR2a, —CO2R2a or —CONR2aR2b, each of methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl is optionally substituted with at least one substituent R2c;
R2a and R2b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, aziridinyl, azetidinyl, pyrrolidinyl, dihydropyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxazolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl is optionally substituted with at least one substituent R2d; or
R2a and R2b together with the carbon atoms to which they are attached, form a 3-, 4-, 5- or 6-membered unsaturated or saturated ring, said ring comprising 0 or 1 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R2d;
R2c and R2d, at each occurrence, are each independently hydrogen (H or D), —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, —OR2e, —CN or —NR2eR2f; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl is optionally substituted with at least one substituent R2g;
R2e and R2fare each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or phenyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or phenyl is optionally substituted with at least one substituent R2hR2g and R2h, at each occurrence, are each independently —F, —Cl, —Br, —I, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl;
preferably, R2 is

### Claim 23

The compound of any one of the preceding claims, wherein R3 is independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or —CN, wherein each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl is optionally substituted with at least one substituent selected from —F, —Cl, —Br, —I, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl;
preferably, R3 is independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or —CN;
more preferably, R3 is independently selected from hydrogen, —F, —Cl, —Br, —I.

### Claim 24

The compound of any one of the preceding claims, wherein R4 is oxo (═O).

### Claim 25

The compound of any one of the preceding claims, wherein R3 and R4 together with the carbon atoms to which they are attached, form a 5- to 6-membered aromatic ring, said ring comprising 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R3a;
R3a is independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —CN, wherein each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl is optionally substituted with at least one substituent selected from —F, —Cl, —Br, —I, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, —C6-C12aryl, or 5- to 12-membered heteroaryl.

### Claim 26

The compound of any one of the preceding claims, wherein R5 is phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, —COR5a, —CO2R5a, or —CONR5aR5b, wherein each of phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5c;
R5a and R5b are each independently selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, oxadiazolyl, triazolyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, oxadiazolyl, triazolyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent Rd; or
R5a and R5b together with the nitrogen atom to which they are attached, form a 3-, 4-, 5-, 6-, 7- or 8-membered unsaturated or saturated ring, said ring comprising 0, 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen or sulfur; said ring is optionally substituted with at least one substituent R5d;
R5c and R5d, at each occurrence, are independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, oxo (═O), —OR5e, —SR5e, —CN, —COR5e, —CO2R5e, —CONR5eR5f, —NR5eR5f, —NR5eCOR5f or —NR5eCO2R5f; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5g;
R5e and R5fare each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8 alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5h;
R5g and R5h are each independently selected from halogen, —OH, —CN, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8 alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl.

### Claim 27

The compound of any one of the preceding claims, wherein R5 is pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl, wherein each of pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, is optionally substituted with at least one substituent R5c;
R5c, at each occurrence, is independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl;
preferably, R5 is benzooxazolyl;
more preferably, R5 is

### Claim 28

The compound of any one of the preceding claims, wherein R5 is —COR5a, —CO2R5a or —CONR5aR5b;
wherein R5a and R5b are each independently selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, oxadiazolyl, triazolyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5d;
R5d, at each occurrence, is independently selected from hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl, imidazopyridinyl, —OR5e or —CN; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5g;
R5e is selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzooxazolyl, benzoimidazolyl, imidazopyridazinyl or imidazopyridinyl is optionally substituted with at least one substituent R5h;
R5g and R5h are each independently selected from halogen, —OH, —CN, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl or 5- to 12-membered heteroaryl;
preferably, R5
—COCH3 or —COCF3.

### Claim 29

The compound of any one of the preceding claims, wherein R6 is H, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, —CN, —OR6a, —NR6aR6b, —COR6a, —CO2R6a, —CONR6aR6b, —COR6a or —NR6aCOR6b, each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl is optionally substituted with at least one substituent R6C;
R6a and R6b are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent Rid;
R6c, at each occurrence, is independently hydrogen, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, 5- to 12-membered heteroaryl, oxo (═O), —OR6e, —SR6e, —CN, —COR6e, —CO2R6e, —CONR6eR6f, —NR6eR6f, —NR6eCOR6f or —NR6eCO2R6f; each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R6g;
R6e and R6f are each independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8 alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl or 5- to 12-membered heteroaryl;
R6d and R6g are each independently selected from —F, —Cl, —Br, —I, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl;

### Claim 30

The compound of any one of the preceding claims, wherein R6 is H, —F, —Cl, —Br, —I, methyl, —CF3, ethyl, —CH2CF3, —CF2CH3, propyl, butyl, pentyl, hexyl, heptyl, octyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, furanyl, thiophenyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, —CN, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy,
preferably,
moiety is

### Claim 31

The compound of any one of the preceding claims, wherein R9 and R10 are each independently selected from H, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl or 5- to 12-membered heteroaryl, each of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl or 5- to 12-membered heteroaryl is optionally substituted with at least one substituent R9a;
R9a, at each occurrence, is independently halogen, —OH, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, C1-8alkoxy-C1-8alkyl-, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 3- to 8-membered heterocyclyl, phenyl, or 5- to 12-membered heteroaryl;
preferably, R9 and R10 are each independently selected from H, —F, —Cl, —Br, —I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C2-8alkenyl, —C2-8alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, phenyl or 5- to 12-membered heteroaryl;
more preferably, R9 and R10 are each independently selected from H, methyl, ethyl, propyl, butyl, pentyl, cyclopropyl, cyclobutyl, cyclopentyl;
more preferably, R9 and R10 are each independently selected from H, cyclopropyl.

### Claim 32

The compound of any one of the preceding claims, wherein the compound is selected from

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

A pharmaceutical composition comprising a compound of any one of claims 1-32 or a pharmaceutically acceptable salt, stereoisomer, tautomer or prodrug thereof, together with a
pharmaceutically acceptable excipient.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

A method of decreasing IL-17 activity by inhibition, which comprises administering to an individual the compound according to any one of claims 1-32, or a pharmaceutically acceptable salt thereof, including the compound of formula (I) or the specific compounds exemplified herein.

### Claim 35 (depends on 34)

The method of claim 34, wherein the disease is selected from cancer.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

Use of a compound of any one of claims 1-32 or a pharmaceutically acceptable salt, stereoisomer, tautomer or prodrug thereof in the preparation of a medicament for treating a disease that can be affected by IL-17.

### Claim 37 (depends on 36)

The use of claim 36, wherein the disease is autoimmune disease or inflammatory disease.

### Claim 38 (depends on 37)

The use of claim 37, wherein the disease is chronic inflammation, psoriasis, spondylarthritis, rheumatoid arthritis or multiple sclerosis.
